BeOne Medicines
ONC
#649
Rank
S$46.32 B
Marketcap
S$418.66
Share price
-2.56%
Change (1 day)
50.35%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

BeOne Medicines (ONC) - Total assets

Total assets on the balance sheet as of September 2025 : S$9.89 Billion

According to BeOne Medicines's latest financial reports the company's total assets are S$9.89 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

BeOne Medicines - Total assets on balance sheet (from 2014 to 2025)

Total assets by year

Year Total assets Change
2024-12-31S$8.04 B4.97%
2023-12-31S$7.66 B-10.35%
2022-12-31S$8.55 B-25.89%
2021-12-31S$11.53 B55.74%
2020-12-31S$7.40 B240.88%
2019-12-31S$2.17 B-29.28%
2018-12-31S$3.07 B119.58%
2017-12-31S$1.39 B138.31%
2016-12-31S$0.58 B255.6%
2015-12-31S$0.16 B133.12%
2014-12-31S$70.85 M373.99%
2013-12-31S$14.94 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Onconova Therapeutics
ONTX
S$23.56 M-99.76%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
S$2.58 B-73.86%๐Ÿ‡บ๐Ÿ‡ธ USA